Thienopyrimidines as Novel Inhibitors of Mycobacterium tuberclosis: Synthesis and In-vitro Studies
作者:P. Rashmi、Laxmi Venkatesh Gurachar Nargund、Kuntal Hazra、J. N. Narendra Sharath Chandra
DOI:10.1002/ardp.201000394
日期:2011.7
A series of novel 5,6‐unsubstituted thieno‐[2,3‐d]‐pyrimidines has been synthesized and tested for growth inhibition of Mycobacterium tuberculosis H37Rv. Of twelve compounds synthesized eleven have shown antimycobacterial activity that differs in potency. Compounds 7b, 7c, 7d, 7e, 7f, and 7g exhibited good antimycobacterial activity. MIC values of the compounds tested were comparable with pyrazinamide
合成了一系列新型 5,6-未取代的噻吩并 [2,3-d]-嘧啶并测试其对结核分枝杆菌 H37Rv 的生长抑制作用。在合成的 12 种化合物中,11 种显示出不同效力的抗分枝杆菌活性。化合物7b、7c、7d、7e、7f和7g表现出良好的抗分枝杆菌活性。所测试化合物的 MIC 值与吡嗪酰胺相当。六种显示出良好抗分枝杆菌活性的化合物也进行了细胞毒性研究,发现其细胞毒性较差。该研究表明,明确需要将注意力集中在噻吩并嘧啶以进一步优化铅。